Skip to main contentSkip to navigationSkip to search
HNSA (, %) SEK
Hansa Biopharma logotype

SAVE THE DATE: Tuesday 3 & Wednesday 4 October 2017, Hansa Medical’s Capital Markets Days, Stockholm & London

Hansa Medical AB (Nasdaq Stockholm: HMED), a biopharmaceutical company focusing on novel immunomodulatory enzymes, will host Capital Markets Days for investors, analysts and media in Stockholm on Tuesday 3 October, 1:00 PM – 5:00 PM CET and in London on Wednesday 4 October at 12:00 PM BST (1:00 PM CET / 7:00 AM ET).

The event in Stockholm will be held at Wallenbergsalen, IVA Konferenscentrum, Grev Turegatan 16, and the event in London will be held at the offices of FTI Consulting, 200 Aldersgate, EC1A 4HD. Both events will be webcast.

Members of Hansa Medical’s management team will present, alongside world-leading transplantation experts.

Full details will be available in the coming months.

If you would like to register at this stage, please RSVP to Annika Nielsen at for the event in Stockholm and to Hanna Skeppner at for the London event.

The information was submitted for publication, through the agency of the contact person set out below, at 8 am CEST on August 23, 2017.